Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the market.
- Agency -.
The drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period.
Complete Report on Drug Delivery Technology Market spread across 252 Pages, Profiling 12 Companies and Supported with 170 Tables and 37 Figures is now available at www.rnrmarketresearch.com/drug-del…arket-report.html .
Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are the factors driving the growth of this market.
- Agency -.
On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.
- Drug Delivery Technology Manufacturers
- Public and Private Physicians
- Healthcare Institutions (Medical Data Centers)
- Research & Clinical Laboratories
- Distributors and Suppliers of Drug Delivery Technologies
- Health Insurance Payers
- Market Research and Consulting Firms
Asia is expected to be fastest-growing region in the drug delivery technology market from 2016 to 2021.Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.
Click Now for PDF Sample Download of this Study Report
The hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to factors such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.
Company Profiles (Overview, Products and Services, Financials, Strategy & Development)
1 Johnson & Johnson Services, Inc.
2 Novartis AG
3 F. Hoffmann-La Roche Ltd.
4 Pfizer, Inc.
5 Bayer AG
6 Antares Pharma, Inc.
7 Becton, Dickinson and Company
8 Glaxosmithkline PLC
10 Merck & Co., Inc.
Drug delivery technology market is segmented into hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. In 2016, hospitals segment expected to account for largest share of market.
This can be primarily attributed to advantages like significant number of inpatient and outpatient visits in hospitals as compared to other end users & requirement of large volumes of drugs and their respective delivery devices to cater to demand of this patient pool.
Connect for More Details for More Information “Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021” report @ www.rnrmarketresearch.com/contacts…uying?rname=90534 .
The drug delivery technology market is segmented based on route of administration, facility of use, and region. On the basis of route of administration, the market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal.
In 2016, the oral drug delivery segment is expected to account for the largest share of the market. The oral route of administration is one of the simplest, most convenient, and safest routes.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: